Rockwell Medical, Inc. (RMTI) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 10 Buy, 2 Hold, 4 Sell.
The consensus price target is $3.00, representing an upside of 223.7% from the current price $0.93.
Analysts estimate Earnings Per Share (EPS) of $0.01 and revenue of $0.10B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.01 vs est $0.01 (missed -157%). 2025: actual $-0.15 vs est $-0.12 (missed -30.4%). Analyst accuracy: 0%.
RMTI Stock — 12-Month Price Forecast
$3.00
▲ +223.66% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Rockwell Medical, Inc., the price target is $3.00.
The average price target represents a +223.66% change from the last price of $0.93.
RMTI Analyst Ratings
Buy
Based on 16 analysts giving stock ratings to Rockwell Medical, Inc. in the past 3 months
EPS Estimates — RMTI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.01
vs Est $0.01
▼ 275.4% off
2025
Actual –$0.15
vs Est –$0.12
▼ 23.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — RMTI
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.101B
vs Est $0.100B
▲ 1.2% off
2025
Actual $0.069B
vs Est $0.070B
▼ 0.4% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
